Cargando…
Methemoglobinemia and hemolytic anemia after COVID-19 infection without identifiable eliciting drug: A case-report
We report a second case of methemoglobinemia and non-autoimmune hemolytic anemia after contracting the SARS-CoV-2 infection in the absence of an identifiable eliciting drug. A 35-year old male without previous known comorbidities was admitted after he was diagnosed with the COVID-19 infection and ha...
Autores principales: | Lopes, Desirée Verde, Lazar Neto, Felippe, Marques, Lais C., Lima, Rodrigo B.O., Brandão, Antonio Adolfo Guerra Soares |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676365/ https://www.ncbi.nlm.nih.gov/pubmed/33235826 http://dx.doi.org/10.1016/j.idcr.2020.e01013 |
Ejemplares similares
-
Refractory Methemoglobinemia Secondary to Topical Dapsone With Subsequent Autoimmune Hemolytic Anemia
por: Cantrell, Catharine, et al.
Publicado: (2022) -
Acute methemoglobinemia with hemolytic anemia following bio-organic plant nutrient compound exposure: Two case reports
por: Malkarnekar, Santoshi Balkrishna, et al.
Publicado: (2014) -
HEMOLYTIC ANEMIA AND METHEMOGLOBINEMIA DUE TO HYDROXYCHLOROQUINE USE FOR COVID-19 TREATMENT IN A GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT PATIENT
por: Lim, Steven, et al.
Publicado: (2020) -
Glucose-6-Phosphate Dehydrogenase Deficiency-Associated Hemolytic Anemia and Methemoglobinemia in a Patient Treated With Hydroxychloroquine in the Era of COVID-19
por: Laslett, Nicole, et al.
Publicado: (2021) -
Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction
por: Tang, Andy Sing Ong, et al.
Publicado: (2021)